Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Directly observed therapy does not help fight tuberculosis

19.04.2006


Directly observed therapy (DOT) has no quantitatively important effect on cure rates or treatment completion in people receiving treatment for tuberculosis (TB). So concludes a systematic review of randomized controlled trials conducted in low-, middle, and high-income countries.



To fight TB people need to take medication regularly for at least six months, but many people fail to complete the regimen. One approach to improving compliance has been to directly observe people as they swallow the tablets. The hope is that this would ensure that the tablets are taken regularly.

One of the problems evaluating these approaches to treating TB has been that various other forms of support are often added at the same time. Some programmes include social support, others include housing, and still others give out food tokens. In this review the Cochrane Review Authors teased out the benefit that came just from the direct observation element of the programme.


Their conclusion was stark. “Randomised controlled trials provide no assurance that the routine use of direct observation in low-income, and middle income countries improves cure or treatment completion in people with TB. Furthermore there is no rigorous evidence to support the use of direct observation for prophylaxis in people with latent TB,” say the Authors.

“DOT is a controversial and expensive intervention, and there appears to be no sound reason to advocate its routine use until we understand the situation in which it may be beneficial,” says lead Author Professor Jimmy Volmink, Deputy Dean of Research, Faculty of Health Sciences, Stellenbosch University, South Africa

Until that evidence is available, the authors recommend that attention is focussed on interventions that boosts patient motivation and provide incentives or support.

Polly Young | alfa
Further information:
http://www.thecochranelibrary.com
http://www.wiley.co.uk

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>